{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:46:08Z","timestamp":1778708768486,"version":"3.51.4"},"reference-count":55,"publisher":"American Society of Hematology","issue":"22","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,29]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Plasma cell dyscrasias encompass a spectrum from the precursors monoclonal gammopathy of undetermined significance and smoldering myeloma to symptomatic myeloma, but the genes that enable progression and confer poor prognosis are incompletely understood. Using single-cell transcriptomics, we identified the caseinolytic protease proteolytic subunit (CLPP), a key component of the mitochondrial caseinolytic protease (CLP) serine endopeptidase, as being overexpressed in CD138+ neoplastic vs normal and in symptomatic vs precursor plasma cells. Its high expression was associated with an adverse prognosis across multiple molecularly defined subgroups in the newly diagnosed and relapsed\/refractory settings and with extramedullary disease. Pharmacologic CLPP inhibition and genetic suppression reduced organoid growth, cell viability, and cell cycle progression, and triggering an unfolded protein response and apoptosis. This occurred in association with mitochondrial transmembrane potential loss and caspase and proteasome activation in a reactive oxygen species\u2013dependent manner. Downstream consequences included autophagy and mitophagy induction and reductions in oxidative phosphorylation and glycolysis with consequent compromise of mitochondrial and cytoplasmic adenosine triphosphate (ATP) production. CLP endopeptidase inhibition overcame conventional and novel drug resistance, induced apoptosis in primary samples, showed efficacy in vivo, and could be achieved with the clinically relevant agent inobrodib. Finally, regimens combining a CLPP and proteasome inhibitor showed enhanced efficacy, as did combinations with inhibitors of intermediary metabolism and autophagy. Taken together, our data indicate that CLPP is a key contributor to transformed plasma cells, a novel mediator of high-risk behavior, and a legitimate target for myeloma therapy whose inhibitors could be rationally combined with current therapeutics to improve outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2024024781","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T15:19:51Z","timestamp":1738855191000},"page":"2614-2629","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma"],"prefix":"10.1182","volume":"145","author":[{"given":"Li","family":"Qin","sequence":"first","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz Yurany","family":"Moreno Rueda","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upasana","family":"Ray","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqbal","family":"Mahmud","sequence":"additional","affiliation":[{"name":"2Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Tan","sequence":"additional","affiliation":[{"name":"2Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-7774","authenticated-orcid":false,"given":"Philip L.","family":"Lorenzi","sequence":"additional","affiliation":[{"name":"2Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-2646","authenticated-orcid":false,"given":"Suyu","family":"Liu","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Lin","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Mery","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-2973","authenticated-orcid":false,"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John D.","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-3398","authenticated-orcid":false,"given":"Qing","family":"Yi","sequence":"additional","affiliation":[{"name":"5Department of Cancer Biology in Medicine, Houston Methodist Dr. Mary and Ron Neal Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Acevedo Calado","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-176X","authenticated-orcid":false,"given":"Elisabet E.","family":"Manasanch","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8545-3292","authenticated-orcid":false,"given":"Hans C.","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-027X","authenticated-orcid":false,"given":"Krina K.","family":"Patel","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isere","family":"Kuiatse","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Symer","sequence":"additional","affiliation":[{"name":"6VA Boston Healthcare System, US Department of Veterans Affairs, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-4129","authenticated-orcid":false,"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[{"name":"1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX"},{"name":"7Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"4","key":"2025052911214459200_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"2025052911214459200_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2025052911214459200_bib3","doi-asserted-by":"crossref","first-page":"a004374","DOI":"10.1101\/cshperspect.a004374","article-title":"Cellular strategies of protein quality control","volume":"3","author":"Chen","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"2025052911214459200_bib4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1182\/blood-2006-04-016360","article-title":"Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma","volume":"109","author":"Jakob","year":"2007","journal-title":"Blood"},{"key":"2025052911214459200_bib5","doi-asserted-by":"crossref","first-page":"684232","DOI":"10.3389\/fonc.2021.684232","article-title":"PSMB7 is a key gene involved in the development of multiple myeloma and resistance to bortezomib","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"2025052911214459200_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.2023.283200","article-title":"Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma","volume":"109","author":"Garcia","year":"2024","journal-title":"Haematologica"},{"key":"2025052911214459200_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-med-112017-091045","article-title":"New drugs in multiple myeloma","volume":"70","author":"Kunacheewa","year":"2019","journal-title":"Annu Rev Med"},{"issue":"13","key":"2025052911214459200_bib8","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood-2008-08-172734","article-title":"The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition","volume":"113","author":"Bianchi","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2025052911214459200_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41419-020-03062-z","article-title":"Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy","volume":"11","author":"Nouri","year":"2020","journal-title":"Cell Death Dis"},{"issue":"2","key":"2025052911214459200_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/10409238.2021.1979461","article-title":"Structure and function of ClpXP, a AAA+ proteolytic machine powered by probabilistic ATP hydrolysis","volume":"57","author":"Sauer","year":"2022","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"2025052911214459200_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abbi.2000.2036","article-title":"Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex","volume":"383","author":"Orlowski","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"2025052911214459200_bib12","doi-asserted-by":"crossref","first-page":"101781","DOI":"10.1016\/j.jbc.2022.101781","article-title":"Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small molecules","volume":"298","author":"Mabanglo","year":"2022","journal-title":"J Biol Chem"},{"key":"2025052911214459200_bib13","doi-asserted-by":"crossref","first-page":"102078","DOI":"10.1016\/j.cbpa.2021.07.003","article-title":"Substrates and interactors of the ClpP protease in the mitochondria","volume":"66","author":"Mabanglo","year":"2022","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"2025052911214459200_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","article-title":"Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality","volume":"35","author":"Ishizawa","year":"2019","journal-title":"Cancer Cell"},{"issue":"6","key":"2025052911214459200_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","article-title":"Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia","volume":"27","author":"Cole","year":"2015","journal-title":"Cancer Cell"},{"issue":"10","key":"2025052911214459200_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.neo.2017.07.009","article-title":"The imipridone ONC201 induces apoptosis and overcomes chemotherapy resistance by up-regulation of Bim in multiple myeloma","volume":"19","author":"Tu","year":"2017","journal-title":"Neoplasia"},{"issue":"6","key":"2025052911214459200_bib17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ccell.2023.05.007","article-title":"Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease","volume":"41","author":"Dang","year":"2023","journal-title":"Cancer Cell"},{"issue":"13","key":"2025052911214459200_bib18","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"12","key":"2025052911214459200_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"6476","key":"2025052911214459200_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.aax0249","article-title":"Single-cell transcriptional diversity is a hallmark of developmental potential","volume":"367","author":"Gulati","year":"2020","journal-title":"Science"},{"issue":"7","key":"2025052911214459200_bib21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","article-title":"Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry","volume":"13","author":"Mertins","year":"2018","journal-title":"Nat Protoc"},{"issue":"47","key":"2025052911214459200_bib22","doi-asserted-by":"crossref","first-page":"32302","DOI":"10.1074\/jbc.M806424200","article-title":"Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machinery","volume":"283","author":"Metzger","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"2025052911214459200_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/leu.2013.174","article-title":"Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications","volume":"28","author":"Bjorklund","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"2025052911214459200_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/15548627.2021.1920818","article-title":"Lipotoxicity reduces DDX58\/Rig-1 expression and activity leading to impaired autophagy and cell death","volume":"18","author":"Frietze","year":"2022","journal-title":"Autophagy"},{"key":"2025052911214459200_bib25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.redox.2017.01.017","article-title":"Mitochondrial contribution to lipofuscin formation","volume":"11","author":"Konig","year":"2017","journal-title":"Redox Biol"},{"issue":"2","key":"2025052911214459200_bib26","doi-asserted-by":"crossref","first-page":"102851","DOI":"10.1016\/j.jbc.2022.102851","article-title":"Analysis of a degron-containing reporter protein GFP-CL1 reveals a role for SUMO1 in cytosolic protein quality control","volume":"299","author":"Wang","year":"2023","journal-title":"J Biol Chem"},{"issue":"1","key":"2025052911214459200_bib27","doi-asserted-by":"crossref","first-page":"e202103033","DOI":"10.1083\/jcb.202103033","article-title":"CHMP2B regulates TDP-43 phosphorylation and cytotoxicity independent of autophagy via CK1","volume":"221","author":"Deng","year":"2022","journal-title":"J Cell Biol"},{"issue":"5","key":"2025052911214459200_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/0008-5472.CAN-21-2342","article-title":"AMPK-mTOR-mediated activation of autophagy promotes formation of dormant polyploid giant cancer cells","volume":"82","author":"You","year":"2022","journal-title":"Cancer Res"},{"issue":"14","key":"2025052911214459200_bib29","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood-2018-06-859686","article-title":"Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma","volume":"133","author":"Zhuang","year":"2019","journal-title":"Blood"},{"issue":"10","key":"2025052911214459200_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/ERC-20-0402","article-title":"Development of improved SRC-3 inhibitors as breast cancer therapeutic agents","volume":"28","author":"Qin","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2025052911214459200_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-0716-0802-9_12","article-title":"The analysis of mycobacterium tuberculosis-induced bioenergetic changes in infected macrophages using an extracellular flux analyzer","volume":"2184","author":"Cumming","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2025052911214459200_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mt.2009.92","article-title":"Converting tumor-specific markers into reporters of oncolytic virus infection","volume":"17","author":"Iankov","year":"2009","journal-title":"Mol Ther"},{"issue":"2","key":"2025052911214459200_bib33","doi-asserted-by":"crossref","first-page":"101925","DOI":"10.1016\/j.xcrm.2024.101925","article-title":"Single-cell analysis of neoplastic plasma cells across identifies myeloma pathobiology mediators and potential targets","volume":"6","author":"Moreno Rueda","year":"2025","journal-title":"Cell Rep Med"},{"issue":"6","key":"2025052911214459200_bib34","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2025052911214459200_bib35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","author":"Usmani","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"2025052911214459200_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bmc.2011.07.047","article-title":"Development and characterization of improved \u03b2-lactone-based anti-virulence drugs targeting ClpP","volume":"20","author":"Zeiler","year":"2012","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"2025052911214459200_bib37","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci"},{"issue":"5","key":"2025052911214459200_bib38","doi-asserted-by":"crossref","first-page":"006924","DOI":"10.1074\/mcp.M110.006924","article-title":"Oxidative stress-mediated regulation of proteasome complexes","volume":"10","author":"Aiken","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"2025052911214459200_bib39","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.ccell.2023.11.001","article-title":"Therapeutic targeting of EP300\/CBP by bromodomain inhibition in hematologic malignancies","volume":"41","author":"Nicosia","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"2025052911214459200_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2017.08.007","article-title":"Metabolic links between plasma cell survival, secretion, and stress","volume":"39","author":"Lam","year":"2018","journal-title":"Trends Immunol"},{"issue":"5","key":"2025052911214459200_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.immuni.2017.04.009","article-title":"Metabolic regulation of the immune humoral response","volume":"46","author":"Boothby","year":"2017","journal-title":"Immunity"},{"issue":"suppl 1","key":"2025052911214459200_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10875-016-0246-9","article-title":"Metabolic control of plasma cell differentiation- what we know and what we don't know","volume":"36","author":"Aronov","year":"2016","journal-title":"J Clin Immunol"},{"issue":"10","key":"2025052911214459200_bib43","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/cancers13102411","article-title":"Targeting reactive oxygen species metabolism to induce myeloma cell death","volume":"13","author":"Caillot","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2025052911214459200_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/EBC20160009","article-title":"Protein quality control at the mitochondrion","volume":"60","author":"Voos","year":"2016","journal-title":"Essays Biochem"},{"issue":"2","key":"2025052911214459200_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41389-021-00306-1","article-title":"LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival","volume":"10","author":"Lee","year":"2021","journal-title":"Oncogenesis"},{"issue":"10","key":"2025052911214459200_bib46","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.celrep.2016.11.027","article-title":"A LON-ClpP proteolytic axis degrades complex I to extinguish ROS production in depolarized mitochondria","volume":"17","author":"Pryde","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"2025052911214459200_bib47","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1105\/tpc.114.124842","article-title":"Conditional depletion of the Chlamydomonas chloroplast ClpP protease activates nuclear genes involved in autophagy and plastid protein quality control","volume":"26","author":"Ramundo","year":"2014","journal-title":"Plant Cell"},{"issue":"7","key":"2025052911214459200_bib48","doi-asserted-by":"crossref","first-page":"e1002507","DOI":"10.1371\/journal.pbio.1002507","article-title":"The mitochondrial unfoldase-peptidase complex ClpXP controls bioenergetics stress and metastasis","volume":"14","author":"Seo","year":"2016","journal-title":"PLoS Biol"},{"issue":"8","key":"2025052911214459200_bib49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/cancers14081905","article-title":"Metabolic vulnerabilities in multiple myeloma","volume":"14","author":"Lim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025052911214459200_bib50","doi-asserted-by":"crossref","first-page":"1155621","DOI":"10.3389\/fonc.2023.1155621","article-title":"Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment","volume":"13","author":"Matamala Montoya","year":"2023","journal-title":"Front Oncol"},{"issue":"3","key":"2025052911214459200_bib51","doi-asserted-by":"crossref","first-page":"e0119857","DOI":"10.1371\/journal.pone.0119857","article-title":"Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells","volume":"10","author":"Zub","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"2025052911214459200_bib52","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.15252\/embj.201694253","article-title":"CLPP coordinates mitoribosomal assembly through the regulation of ERAL1 levels","volume":"35","author":"Szczepanowska","year":"2016","journal-title":"EMBO J"},{"issue":"10","key":"2025052911214459200_bib53","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2174\/092986709787846578","article-title":"Mitochondrial respiratory complex I: structure, function and implication in human diseases","volume":"16","author":"Sharma","year":"2009","journal-title":"Curr Med Chem"},{"issue":"10","key":"2025052911214459200_bib54","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.3390\/ijms21103412","article-title":"Reactive oxygen species, metabolic plasticity, and drug resistance in cancer","volume":"21","author":"Bhardwaj","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2025052911214459200_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/0113894501274958231220053714","article-title":"ClpP peptidase as a plausible target for the discovery of novel antibiotics","volume":"25","author":"Bhardwaj","year":"2024","journal-title":"Curr Drug Targets"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/22\/2614\/2376671\/blood_bld-2024-024781-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/22\/2614\/2376671\/blood_bld-2024-024781-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T15:21:56Z","timestamp":1748532116000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/22\/2614\/535462\/Targeting-caseinolytic-mitochondrial-matrix"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,5,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024024781","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,29]]},"published":{"date-parts":[[2025,5,29]]}}}